Core Viewpoint - SBC Medical Group Holdings Incorporated is set to release its financial results for Q4 and the fiscal year ending December 31, 2025, on March 27, 2026, before the U.S. market opens [1] Group 1: Financial Results Announcement - The earnings conference call will take place on March 27, 2026, at 8:30 a.m. Eastern Time, where management will discuss financial performance, operational highlights, and key priorities for 2026 [2] - Registration for the conference call is required, and materials including the earnings release and archived webcast will be available on the Company's Investor Relations website [2] Group 2: Company Overview - SBC Medical operates as a Management Services Organization with a diverse portfolio in medical fields such as aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment, and ophthalmology [3] - The Company is expanding its global presence, particularly in the U.S. and Asia, through direct operations and medical tourism initiatives [3] - SBC Medical was listed on Nasdaq in September 2024 and included in the Russell 3000® Index in June 2025, reflecting its growth and market presence [3] - The Company aims to contribute to global well-being through medical innovation, providing high-quality medical services while enhancing its international reputation [3]